Home and Self-Injection of Sayana® Press in Ethiopia: Qualitative Study
This qualitative study investigated the perceptions and policy implications of home and self-injection of Sayana® Press in Ethiopia’s Oromia region. Sayana® Press is the subcutaneous formulation of the three-month injectable depot medroxyprogesterone acetate (DMPA) in the Uniject™ injection system. This study did not include actual product use in humans.
Publication date: May 2013
Available materials
-
-
Feasibility of Home and Self-Injection of Sayana® Press in Ethiopia: Results of a Qualitative Study (summary)
- PDF
Hard copies are not available.
-
Perceptions of Home and Self-Injection of Sayana® Press in Ethiopia: Final Qualitative Study Report
- PDF
Hard copies are not available.
-
Feasibility of Home and Self-Injection of Sayana® Press in Ethiopia: Results of a Qualitative Study (summary)
- PDF